8-K//Current report
AN2 Therapeutics, Inc. 8-K
Accession 0001193125-25-127595
$ANTXCIK 0001880438operating
Filed
May 26, 8:00 PM ET
Accepted
May 27, 4:30 PM ET
Size
149.7 KB
Accession
0001193125-25-127595
Documents
- 8-Kd82533d8k.htmPrimary
8-K
- EX-101.SCHantx-20250522.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABantx-20250522_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREantx-20250522_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001193125-25-127595-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLd82533d8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
AN2 Therapeutics, Inc.
CIK 0001880438
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001880438
Filing Metadata
- Form type
- 8-K
- Filed
- May 26, 8:00 PM ET
- Accepted
- May 27, 4:30 PM ET
- Size
- 149.7 KB